An early study suggested that CD34+CD4− and CD34+CD7− cells, which make up a fraction of the leukemic cells from pediatric T-ALL patients, had leukemia-initiating properties when engrafted into NOD/SCID mice (5). The gene discussed is CD34; the disease is acute lymphoblastic leukemia.